RankAlpha logo
Back to Rankings

BRNS

Barinthus BiotherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
BRNS vs peer average
44/100
BRNS vs. peer average (D vs. D)
Grade spread
A 2 · C 1 · D 1 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

CNSY is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $24.29M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCNSYCerenome
BRNS
Barinthus Biotherapeutics
CNSY
Cerenome
Grade
D
F
Momentum
9
0
Value
58
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs CNSY

BRNS / CNSY
Grade Position
Below peers
BRNS vs. peer average (D vs. D)
44/100
Momentum
9
BRNS
Value
58
BRNS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs BRNS
1
CNSY
Cerenome Inc Common
F
20/100
+1
2
CLRB
Cellectar Biosciences Inc Common
A
100/100
-3
3
QNTM
Quantum Biopharma Ltd Subordinate Voting Shares Class B Common
C
60/100
-1
4
ACTU
Actuate Therapeutics Inc Common
F
20/100
+1
5
TVRD
Tvardi Therapeutics Inc Common
F
20/100
+1
CNSY is the first peer returned for this comparison set.